| Catalog Number |
305209 |
| Medical Device Problem Code |
Missing Information (4053)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
10/27/2023
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
It was reported that the bd oral syringe label content was missing.The following information was provided from the initial reporter: "expiry date not mentioned on bag.".
|
| |
|
Additional Manufacturer Narrative
|
|
B.3.The date received by manufacturer has been used for this field.H.3.If a device evaluation and/or device history review is completed, a supplemental report will be filed.
|
| |
|
Additional Manufacturer Narrative
|
|
(b)(4) ¿ follow up mdr for device evaluation.No samples or photos received by our quality team for evaluation.Though please note that this product does not have an expiration date.The reported defect is not a true defect and is a design-related inquiry.Batch 0148085 is considered in compliance with our product specification requirements.We appreciate you taking the time to bring this observation to our attention.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored monthly.Our business team regularly reviews the collected data for identification of emerging trends.H3 other text : see h10 manufacture narrative.
|
| |
|
Event or Problem Description
|
|
No additional information.
|
| |
|
Event or Problem Description
|
|
No additional information.
|
| |
|
Additional Manufacturer Narrative
|
|
Becton dickinson and company's (bd) medication delivery solutions (mds) business unit will discontinue malfunction mdr reporting for certain device failures that have not caused or contributed to deaths or serious injuries in the past two years, and where the likelihood of a death or serious injury as a result of these malfunctions is remote.This decision follows fda guidelines (medical device reporting for manufacturers guidance for industry and food and drug administration staff issued nov 8, 2016, reference section 2.15).Bd notified fda of this decision on mar 3, 2025.Fda has reviewed and responded to bd¿s notification (reference fda document#: (b)(4) on march 7, 2025.This documentation is available in bd document management system (sap) as (b)(4).This supplemental mdr is being filed to document that the below device failure will no longer be considered a reportable malfunction mdr for the product family below: product family: enteral/oral syringes.Device failure: labeling concerns.
|
| |
|
Search Alerts/Recalls
|